3H-[1,2,3]triazolo[4,5-d]pyrimidine compounds, their use as mTOR kinase and PI3 kinase inhibitors, and their syntheses

Details for Australian Patent Application No. 2009205501 (hide)

Owner Wyeth LLC

Inventors Dehnhardt, Christoph Martin; AyralKaloustian, Semiramis; Chen, Zecheng; Verheijen, Jeroen Cunera; Dos Santos, Osvaldo; Delos Santos, Efren Guillermo; Zask, Arie; Venkatesan, Aranapakam Mudumbai; Brooijmans, Natasja

Agent Spruson & Ferguson

Pub. Number AU-A-2009205501

PCT Pub. Number WO2009/091788

Priority 61/021,084 15.01.08 US; 61/034,680 07.03.08 US

Filing date 14 January 2009

Wipo publication date 23 July 2009

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

5 August 2010 PCT application entered the National Phase

  PCT publication WO2009/091788 Priority application(s): WO2009/091788

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009205523-Compositions, methods, and kits for detecting ribonucleic acid

2009205489-Policy control and charging (PCC) rules based on mobility protocol